Ephedra
This article was originally published in The Tan Sheet
Executive Summary
California Senate bill 397 suspended indefinitely in Assembly Appropriations Committee Sept. 10, according to state clerk's office. Last amended Aug. 28, bill would limit ephedrine alkaloid product sales to people over 18 and require MedWatch number on labeling. No timeframe for continued Assembly discussions on the issue has been announced. Separately, National Football League announces ephedra ban Sept. 8, although officials note testing plan for the substance is still being formed
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: